Sentinel API Group

We offer re-shoring of pharmaceutical ingredient manufacturing to help resupply the US stockpile

Tampa, United States (USA)

1 Followers

Overview

Legal Form

Inc

Phase

Prototype

Founded

2025

Team Size

6-10

Industries

Biotech & PharmaceuticalsChemicals & MaterialsHealthcare & Medical Devices

Impacts

Healthcare AccessGlobal HealthJob CreationLocal Economic DevelopmentSupply Chain SustainabilityDisaster Relief & Preparedness

What Drives Us

Mission

Sentinel restores U.S. production of essential generic APIs by retrofitting modular, federally aligned GMP facilities that are DMF-ready from day one and designed to pair equity with matching grants for resilient domestic supply.

Problem

Sentinel solves the collapse of U.S. generic API manufacturing, where 92% of top antibiotics have no domestic source and national capacity has fallen to <2% of former output, leaving the country dependent on fragile offshore supply chains. We rebuild this capability by retrofitting federally aligned, grant-leveraged GMP facilities that produce essential APIs domestically and meet new OBBB and SAPIR procurement mandates.

Solution

Sentinel restores U.S. API manufacturing by retrofitting modular, federally aligned GMP facilities that produce DMF-ready essential generics without R&D lag. The model pairs equity with matching federal grants and meets new OBBB/SAPIR procurement mandates to rebuild reliable, domestic pharmaceutical supply.